XML 79 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Note 3 - Acquisition of UEX Corporation
12 Months Ended
Jul. 31, 2024
UEX Acquisition [Member]  
Notes to Financial Statements  
Asset Acquisition [Text Block]

NOTE 3:

ACQUISITION OF UEX CORPORATION

 

During Fiscal 2022, on June 13, 2022, we entered into a definitive agreement with UEX Corporation (“UEX” and the “UEX Agreement”) pursuant to which we would acquire all of the issued and outstanding common shares of UEX in an all-share transaction (the “UEX Acquisition”).  On June 21, 2022, in accordance with the UEX Agreement, we completed a private placement in UEX, whereby we acquired 11,627,907 UEX common shares at a price of CA$0.43 per UEX common share for total consideration of $3,867. In Fiscal 2022, we also acquired an additional 6,844,000 UEX common shares for total consideration of $1,914 by making purchases of UEX common shares through the facilities of the Toronto Stock Exchange subject to and in accordance with applicable laws.

 

On August 19, 2022, we acquired all of the issued and outstanding common shares of UEX that we did not already own pursuant to the completion of the UEX Acquisition.  Pursuant to the terms of the UEX Acquisition, UEX shareholders received 0.09 common shares of UEC for each UEX common share held.  As a result, we issued 48,518,745 shares of our Company in exchange for the common shares of UEX that we did not already own.  The UEX shares we owned before closing the UEX Acquisition were returned to treasury.

 

In connection with the UEX Acquisition, we also issued 2,301,750 stock options (the “Replacement Options”) and 4,660,580 warrants (the “Replacement Warrants”) to replace the outstanding stock options and warrants of UEX that were outstanding immediately prior to the completion of the UEX Acquisition.

 

The estimated fair value of the Replacement Options in the amount of $4,026 as of August 19, 2022 was classified as equity and presented in additional paid in capital in accordance with ASC 718 Compensation – Stock Compensation.  The fair value of the Replacement Options was estimated using the Black-Scholes model with the following assumptions, which is level 2 of the fair value measurement hierarchy:

 

Exercise Price in U.S. dollars

 

1.077 to3.9494

 

Exercise Price in Canadian dollars

 

CA$1.39 to CA$5.12

 

Expected Risk Free Interest Rate

 2.40% to 3.23% 

Expected Volatility

 76.01% to 97.53% 

Expected Life in Years

 0.12 to 1.0 

Expected Dividend Yield

 0.00%

 

The estimated fair value of the Replacement Warrants in the amount of $8,903 as of August 19, 2022 was classified as derivative liabilities in accordance with ASC 815 Derivatives and Hedging, as the exercise prices of the Replacement Warrants are denominated in Canadian dollars, which differs from the Company’s functional currency.  The change in fair value on the derivative liabilities is recorded as a change in fair value of derivative liability in our consolidated statements of operations.  The fair value of the Replacement Warrants on August 19, 2022 was estimated using the Black-Scholes model with the following assumptions, which is level 2 of the fair value measurement hierarchy:

 

Exercise Price in U.S. dollars

 

1.111 to3.4242

 

Exercise Price in Canadian dollars

 

CA$1.44 to CA$4.44

 

Expected Risk Free Interest Rate

 3.18% to 3.23% 

Expected Volatility

 90.98% to 101.52% 

Expected Life in Years

 0.75 to 2.05 

Expected Dividend Yield

 0.00%

 

The UEX Acquisition is accounted for as an acquisition of assets rather than a business as UEX did not meet the definition of a business in accordance with ASC 805 Business Combinations.

 

The following table summarizes the fair value of the consideration paid, and the fair value of the assets acquired and liabilities assumed, on the closing date of the UEX Acquisition:

 

Consideration paid

    

UEC shares issued

 $171,271 

Fair value of UEX shares acquired by UEC before acquisition

  5,830 

Replacement options issued

  4,026 

Replacement warrants issued

  8,903 

Acquisition related costs

  2,643 

Total consideration

 $192,673 
     

Assets acquired and liabilities assumed

    

Cash and cash equivalents

 $4,627 

Prepaid expenses and deposits

  159 

Accounts receivable

  892 

Mineral rights and properties

  208,008 

Equity-accounted investment

  24,502 

Investment in equity securities

  135 

Other non-current assets

  118 

Total assets

  238,441 
     

Accounts payable and accrued liabilities

  7,080 

Other liabilities

  111 

Asset retirement obligations (Note 14)

  211 

Deferred tax liabilities

  38,366 

Total liabilities

  45,768 

Total net assets

 $192,673 

 

The Company recognized the assets and liabilities acquired in this acquisition by allocating the cost of the acquisition to the assets and liabilities based on their relative fair values. The fair value of the mineral rights and properties and equity-accounted investment was based on a value per pound of uranium which was determined using an in situ multiples analysis.  Management used data from comparable public companies and precedent transactions in the in situ multiples analysis to estimate a  value per pound of uranium and apply that to the property resource estimates, taking into account project-specific characteristics.  The property resource estimates were based on information prepared by qualified persons (management’s specialists).

 

Cash flow on acquisition:

Cash acquired with the subsidiary

 $4,627 

Acquisition related costs

  (2,643)

Acquisition of UEX, net of cash acquired

 $1,984